Literature DB >> 16020613

Management of hypertension in ethnic minorities.

Jawad M Khan1, D Gareth Beevers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16020613      PMCID： PMC1769018          DOI： 10.1136/hrt.2004.044560

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  22 in total

1.  The efficacy and safety of valsartan compared with placebo in the treatment of patients with essential hypertension.

Authors:  S Oparil; S Dyke; F Harris; J Kief; D James; A Hester; S Fitzsimmons
Journal:  Clin Ther       Date:  1996 Sep-Oct       Impact factor: 3.393

2.  Influence of race and dietary salt on the antihypertensive efficacy of an angiotensin-converting enzyme inhibitor or a calcium channel antagonist in salt-sensitive hypertensives.

Authors:  M R Weir; S G Chrysant; D A McCarron; M Canossa-Terris; J D Cohen; P A Gunter; A J Lewin; R F Mennella; L W Kirkegaard; J H Hamilton; M H Weinberger; A B Weder
Journal:  Hypertension       Date:  1998-05       Impact factor: 10.190

3.  Heart attack, stroke, diabetes, and hypertension in West Indians, Asians, and whites in Birmingham, England.

Authors:  J K Cruickshank; D G Beevers; V L Osbourne; R A Haynes; J C Corlett; S Selby
Journal:  Br Med J       Date:  1980-10-25

4.  A comparison of the efficacy and safety of a beta-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks.

Authors:  E Saunders; M R Weir; B W Kong; J Hollifield; J Gray; V Vertes; J R Sowers; M B Zemel; C Curry; J Schoenberger
Journal:  Arch Intern Med       Date:  1990-08

5.  Prevalence, detection, and management of cardiovascular risk factors in different ethnic groups in south London.

Authors:  F P Cappuccio; D G Cook; R W Atkinson; P Strazzullo
Journal:  Heart       Date:  1997-12       Impact factor: 5.994

Review 6.  Lessons on the interaction of race and antihypertensive drugs from the VA cooperative study group on antihypertensive agents.

Authors:  B J Materson
Journal:  Am J Hypertens       Date:  1995-12       Impact factor: 2.689

7.  British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary.

Authors:  Bryan Williams; Neil R Poulter; Morris J Brown; Mark Davis; Gordon T McInnes; John F Potter; Peter S Sever; Simon McG Thom
Journal:  BMJ       Date:  2004-03-13

8.  Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

Authors:  B J Materson; D J Reda; W C Cushman; B M Massie; E D Freis; M S Kochar; R J Hamburger; C Fye; R Lakshman; J Gottdiener
Journal:  N Engl J Med       Date:  1993-04-01       Impact factor: 91.245

9.  Comparison of propranolol or hydrochlorothiazide alone for treatment of hypertension. III. Evaluation of the renin-angiotensin system.

Authors:  E D Freis; B J Materson; V Flamenbaum
Journal:  Am J Med       Date:  1983-06       Impact factor: 4.965

10.  Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians.

Authors:  P M McKeigue; B Shah; M G Marmot
Journal:  Lancet       Date:  1991-02-16       Impact factor: 79.321
View more
  19 in total

Review 1.  Hypertension in Bangladesh: a review.

Authors:  A K M Monwarul Islam; Abdullah A S Majumder
Journal:  Indian Heart J       Date:  2012 May-Jun

2.  Flaws in the U.S. Food and Drug Administration's rationale for supporting the development and approval of BiDil as a treatment for heart failure only in black patients.

Authors:  George T H Ellison; Jay S Kaufman; Rosemary F Head; Paul A Martin; Jonathan D Kahn
Journal:  J Law Med Ethics       Date:  2008       Impact factor: 1.718

Review 3.  Social Determinants of Racial Disparities in CKD.

Authors:  Jenna M Norton; Marva M Moxey-Mims; Paul W Eggers; Andrew S Narva; Robert A Star; Paul L Kimmel; Griffin P Rodgers
Journal:  J Am Soc Nephrol       Date:  2016-05-13       Impact factor: 10.121

4.  Knowledge of cardiovascular risk factors in West African refugee women living in Western Australia.

Authors:  Peter D Drummond; Ayse Mizan; Amy Burgoyne; Bernadette Wright
Journal:  J Immigr Minor Health       Date:  2011-02

Review 5.  Candesartan cilexetil: a pharmacoeconomic review of its use in chronic heart failure and hypertension.

Authors:  Greg L Plosker; Susan J Keam
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

Review 6.  Racial differences in blood pressure response to calcium channel blocker monotherapy: a meta-analysis.

Authors:  Thu T Nguyen; Jay S Kaufman; Eric A Whitsel; Richard S Cooper
Journal:  Am J Hypertens       Date:  2009-06-04       Impact factor: 2.689

7.  24-Hour ambulatory blood pressure response to combination valsartan/hydrochlorothiazide and amlodipine/hydrochlorothiazide in stage 2 hypertension by ethnicity: the EVALUATE study.

Authors:  Jackson T Wright; Yves Lacourcière; Rita Samuel; Dion Zappe; Das Purkayastha; Henry R Black
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-09-24       Impact factor: 3.738

8.  Peripheral and central blood pressure responses of combination aliskiren/hydrochlorothiazide and amlodipine monotherapy in African American patients with stage 2 hypertension: the ATLAAST trial.

Authors:  Keith C Ferdinand; James Pool; Richard Weitzman; Das Purkayastha; Raymond Townsend
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-01-18       Impact factor: 3.738

9.  Progress report on the first sub-Saharan Africa trial of newer versus older antihypertensive drugs in native black patients.

Authors:  Augustine N Odili; Birinus Ezeala-Adikaibe; Mouhamadou B Ndiaye; Benedict C Anisiuba; Marius M Kamdem; Chinwuba K Ijoma; Joseph Kaptue; Hilaire J Boombhi; Philip M Kolo; Elvis N Shu; Lutgarde Thijs; Jan A Staessen; Babatunde A Omotoso; Samuel Kingue; Serigne A Ba; Daniel Lemogoum; Jean-René M'Buyamba-Kabangu; Ifeoma I Ulasi
Journal:  Trials       Date:  2012-05-17       Impact factor: 2.279

10.  Efficacy of newer versus older antihypertensive drugs in black patients living in sub-Saharan Africa.

Authors:  J R M'Buyamba-Kabangu; B C Anisiuba; M B Ndiaye; D Lemogoum; L Jacobs; C K Ijoma; L Thijs; H J Boombhi; J Kaptue; P M Kolo; J B Mipinda; C E Osakwe; A Odili; B Ezeala-Adikaibe; S Kingue; B A Omotoso; S A Ba; I I Ulasi; J A Staessen
Journal:  J Hum Hypertens       Date:  2013-06-27       Impact factor: 3.012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.